1999
Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting Cells
Shlomchik W, Couzens M, Tang C, McNiff J, Robert M, Liu J, Shlomchik M, Emerson S. Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting Cells. Science 1999, 285: 412-415. PMID: 10411505, DOI: 10.1126/science.285.5426.412.Peer-Reviewed Original ResearchConceptsAntigen-presenting cellsAllogeneic bone marrow transplantationBone marrow transplantationHost diseaseMarrow transplantationT cellsMurine allogeneic bone marrow transplantation modelAllogeneic bone marrow transplantation modelHost-derived antigen-presenting cellsGraft Versus Host DiseaseHost antigen-presenting cellsDonor antigen-presenting cellsVersus Host DiseaseDonor T cellsAllogeneic T cellsBone marrow transplantation modelAlloimmune attackHost antigensTransplantation modelImportant toxicityNeoplastic diseaseDiseaseGraftTransplantationHost tissues
1994
Pathology of the lymph nodes in patients with malignant melanoma.
Cochran A, Robert M, Wen D. Pathology of the lymph nodes in patients with malignant melanoma. Pathology 1994, 2: 385-400. PMID: 9420909.Peer-Reviewed Original ResearchMeSH KeywordsHumansLymph Node ExcisionLymph NodesLymphatic MetastasisMelanomaPrognosisRisk FactorsSkin NeoplasmsConceptsMalignant melanomaLymph nodesLymph node metastases of malignant melanomaMetastases of malignant melanomaRegional lymph node metastasisLymph node dissectionPathological risk factorsPoor survival rateDifficulty of diagnosisVisceral metastasesSelective lymphadenectomyNode dissectionSurvival rateRisk factorsClinical considerationsLymphMelanomaPatientsLymphadenectomyMetastasisPrognosisDissection
1993
Pathological evaluation of the regional lymph nodes in malignant melanoma.
Robert M, Wen D, Cochran A. Pathological evaluation of the regional lymph nodes in malignant melanoma. Seminars In Diagnostic Pathology 1993, 10: 102-15. PMID: 8506413.Peer-Reviewed Original ResearchConceptsLymph node metastasisNode metastasisMalignant melanomaLymph nodesDevelopment of lymph node metastasesPrognostic significance of metastasisDiagnosis of metastatic melanomaClinical stage II diseaseSurvival rateFive-year survival rateStage I melanomaDetection of micrometastasesPathological risk factorsStage II diseaseRegional lymph nodesMetastatic melanomaII diseasePrognostic significancePathological evaluationDifferential diagnosisMelanomaRisk factorsMetastasisClinical implicationsLymph